{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T21:10:23Z","timestamp":1760735423968,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ejca.2021.08.040","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T13:18:45Z","timestamp":1632835125000},"page":"424-427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Troponin increase during immunotherapy: Not always myocarditis"],"prefix":"10.1016","volume":"157","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5746-9246","authenticated-orcid":false,"given":"Erwin","family":"Benassaia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0938-1976","authenticated-orcid":false,"given":"Anais","family":"Vallet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6316-5668","authenticated-orcid":false,"given":"Etienne","family":"Rouleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Ederhy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Robert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejca.2021.08.040_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/jcp.2005.035105","article-title":"Cardiac metastases","volume":"60","author":"Bussani","year":"2007","journal-title":"J Clin Pathol"},{"issue":"4","key":"10.1016\/j.ejca.2021.08.040_bib2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1470-2045(05)70093-0","article-title":"Cardiac tumours: diagnosis and management","volume":"6","author":"Butany","year":"2005","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2021.08.040_bib3","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S1470-2045(19)30388-2","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study","volume":"20","author":"Robert","year":"2019","journal-title":"Lancet Oncol"},{"issue":"16","key":"10.1016\/j.ejca.2021.08.040_bib4","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jacc.2018.02.037","article-title":"Myocarditis in patients treated with immune checkpoint inhibitors","volume":"71","author":"Mahmood","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.ejca.2021.08.040_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018403","article-title":"Cardiovascular toxicity related to cancer treatment: a pragmatic approach to the American and European cardio-oncology guidelines","volume":"9","author":"Alexandre","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"10.1016\/j.ejca.2021.08.040_bib6","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1016\/j.jcmg.2020.03.021","article-title":"Diagnostic accuracy of cardiac computed tomography and 18-F Fluorodeoxyglucose positron emission tomography in cardiac masses","volume":"13","author":"D'Angelo","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.ejca.2021.08.040_bib7","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s12350-011-9422-8","article-title":"Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake","volume":"18","author":"Harisankar","year":"2011","journal-title":"J Nucl Cardiol"},{"issue":"3","key":"10.1016\/j.ejca.2021.08.040_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/anec.12726","article-title":"Diagnostic and prognostic role of electrocardiogram in acute myocarditis: a comprehensive review","volume":"25","author":"Butt\u00e0","year":"2020","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"11","key":"10.1016\/j.ejca.2021.08.040_bib9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41571-020-0399-6","article-title":"Immunotherapy discontinuation - how, and when? Data from melanoma as a paradigm","volume":"17","author":"Robert","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2021.08.040_bib10","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cell.2020.10.027","article-title":"Persistent cancer cells: the deadly survivors","volume":"183","author":"Shen","year":"2020","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.ejca.2021.08.040_bib11","first-page":"4064","article-title":"Shahneen sandhu longitudinal monitoring of ctDNA in patients with melanoma and brain metastases treated with immune checkpoint inhibitors","volume":"26","author":"Lee","year":"2020","journal-title":"Cancer Res"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804921005712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804921005712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:35:45Z","timestamp":1760733345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804921005712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":11,"alternative-id":["S0959804921005712"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2021.08.040","relation":{},"ISSN":["0959-8049"],"issn-type":[{"type":"print","value":"0959-8049"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Troponin increase during immunotherapy: Not always myocarditis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2021.08.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}